Jean-Louis Edme
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Louis Edme has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
A. Sobaszek
8 shared publicationsC. Boulenguez
8 shared publicationsR. Matran
8 shared publicationsP. Frimat
6 shared publications- Annie Sobaszek
Service de médecine du travail du personnel hospitalier, CHU de Lille, 1, rue Michel-Polonovski CS 70001, 59037 Lille cédex, France
5 shared publications A. Leroyer
CERESTE, Université Lille 2, Lille
4 shared publications
Latest Publications
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A73-A74
Profil ventilatoire spirométrique chez 9526 patients français : implication de l’application des nouvelles normes GLI-2012
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A73-A74
Profil ventilatoire spirométrique chez 9526 patients français : implication de l’application des nouvelles normes GLI-2012
- Open Access
- 1 November 2016
- Published by Elsevier in Toxicology Letters
- Vol. 263, 26-33
Effects of occupational exposure to poorly soluble forms of beryllium on biomarkers of pulmonary response in exhaled breath of workers in machining industries
- 1 November 2016
- Published by Elsevier in Toxicology Letters
- Vol. 263, 26-33
Open AccessEffects of occupational exposure to poorly soluble forms of beryllium on biomarkers of pulmonary response in exhaled breath of workers in machining industries
- 1 January 2016
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 219 (1) , 40-47
Beryllium in exhaled breath condensate as a biomarker of occupational exposure in a primary aluminum production plant
- 1 January 2016
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 219 (1) , 40-47
Beryllium in exhaled breath condensate as a biomarker of occupational exposure in a primary aluminum production plant
- 1 December 2015
- Published by Elsevier in Respiratory Medicine
- Vol. 109 (12) , 1553-1561
Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: The ELISABET study 2011–2013
- 1 December 2015
- Published by Elsevier in Respiratory Medicine
- Vol. 109 (12) , 1553-1561
Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: The ELISABET study 2011–2013
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A39
Prévalence des troubles ventilatoires obstructifs chez des adultes du nord de la France issus de l’enquête ELISABET 2011–2013
- 1 January 2015
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 32, A39
Prévalence des troubles ventilatoires obstructifs chez des adultes du nord de la France issus de l’enquête ELISABET 2011–2013
- 1 November 2014
- Published by Elsevier in Archives des Maladies Professionnelles et de l'Environnement
- Vol. 75 (5) , 538-539
Épreuve d’effort cardio-pulmonaire ou métabolique
- 1 November 2014
- Published by Elsevier in Archives des Maladies Professionnelles et de l'Environnement
- Vol. 75 (5) , 538-539
Épreuve d’effort cardio-pulmonaire ou métabolique
- 1 November 2014
- Published by Elsevier in Archives des Maladies Professionnelles et de l'Environnement
- Vol. 75 (5) , 539-540
Évaluation cardio-pulmonaire en Santé Travail
- 1 November 2014
- Published by Elsevier in Archives des Maladies Professionnelles et de l'Environnement
- Vol. 75 (5) , 539-540
Évaluation cardio-pulmonaire en Santé Travail
- 1 April 2014
- Published by Elsevier in Toxicology Letters
- Vol. 226 (1) , 63-69
Manganese in exhaled breath condensate: A new marker of exposure to welding fumes
- 1 April 2014
- Published by Elsevier in Toxicology Letters
- Vol. 226 (1) , 63-69
Manganese in exhaled breath condensate: A new marker of exposure to welding fumes
- 1 June 2013
- Published by Elsevier in Journal de Radiologie Diagnostique et Interventionnelle
- Vol. 94 (6) , 626-635
Emphysème chez les fumeurs asymptomatiques : évaluation quantitative par TDM et corrélations fonctionnelles respiratoires
- 1 June 2013
- Published by Elsevier in Journal de Radiologie Diagnostique et Interventionnelle
- Vol. 94 (6) , 626-635
Emphysème chez les fumeurs asymptomatiques : évaluation quantitative par TDM et corrélations fonctionnelles respiratoires
- Open Access
- 1 December 2011
- Published by Springer Nature in Respiratory Research
- Vol. 12 (1) , 64
AMP-activated protein kinase deficiency reduces ozone-induced lung injury and oxidative stress in mice
Background: Acute ozone exposure causes lung oxidative stress and inflammation leading to lung injury. At least one mechanism underlying the lung toxicity of ozone involves excessive production of reactive oxygen and nitrogen intermediates such as peroxynitrite. In addition and beyond its major prooxidant properties, peroxynitrite may nitrate tyrosine residues altering phosphorylation of many protein kinases involved in cell signalling. It was recently proposed that peroxynitrite activates 5'-AMP-activated kinase (AMPK), which regulates metabolic pathways and the response to cell stress. AMPK activation as a consequence of ozone exposure has not been previously evaluated. First, we tested whether acute ozone exposure in mice would impair alveolar fluid clearance, increase lung tissue peroxynitrite production and activate AMPK. Second, we tested whether loss of AMP-activated protein kinase alpha1 subunit in mouse would prevent enhanced oxidative stress and lung injury induced by ozone exposure. Methods: Control and AMPKα1 deficient mice were exposed to ozone at a concentration of 2.0 ppm for 3 h in glass cages. Evaluation was performed 24 h after ozone exposure. Alveolar fluid clearance (AFC) was evaluated using fluorescein isothiocyanate tagged albumin. Differential cell counts, total protein levels, cytokine concentrations, myeloperoxidase activity and markers of oxidative stress, i.e. malondialdehyde and peroxynitrite, were determined in bronchoalveolar lavage (BAL) and lung homogenates (LH). Levels of AMPK-Thr172 phosphorylation and basolateral membrane Na(+)-K(+)-ATPase abundance were determined by Western blot. Results: In control mice, ozone exposure induced lung inflammation as evidence by increased leukocyte count, protein concentration in BAL and myeloperoxidase activity, pro-inflammatory cytokine levels in LH. Increases in peroxynitrite levels (3 vs 4.4 nM, p = 0.02) and malondialdehyde concentrations (110 vs 230 μmole/g wet tissue) were detected in LH obtained from ozone-exposed control mice. Ozone exposure consistently increased phosphorylated AMPK-Thr172 to total AMPK ratio by 80% in control mice. Ozone exposure causes increases in AFC and basolateral membrane Na(+)-K(+)-ATPase abundance in control mice which did not occur in AMPKα1 deficient mice. Conclusions: Our results collectively suggest that AMPK activation participates in ozone-induced increases in AFC, inflammation and oxidative stress. Further studies are needed to understand how the AMPK pathway may provide a novel approach for the prevention of ozone-induced lung injury.
- 1 December 2011
- Published by Springer Nature in Respiratory Research
- Vol. 12 (1) , 64
Open AccessAMP-activated protein kinase deficiency reduces ozone-induced lung injury and oxidative stress in mice
Background: Acute ozone exposure causes lung oxidative stress and inflammation leading to lung injury. At least one mechanism underlying the lung toxicity of ozone involves excessive production of reactive oxygen and nitrogen intermediates such as peroxynitrite. In addition and beyond its major prooxidant properties, peroxynitrite may nitrate tyrosine residues altering phosphorylation of many protein kinases involved in cell signalling. It was recently proposed that peroxynitrite activates 5'-AMP-activated kinase (AMPK), which regulates metabolic pathways and the response to cell stress. AMPK activation as a consequence of ozone exposure has not been previously evaluated. First, we tested whether acute ozone exposure in mice would impair alveolar fluid clearance, increase lung tissue peroxynitrite production and activate AMPK. Second, we tested whether loss of AMP-activated protein kinase alpha1 subunit in mouse would prevent enhanced oxidative stress and lung injury induced by ozone exposure. Methods: Control and AMPKα1 deficient mice were exposed to ozone at a concentration of 2.0 ppm for 3 h in glass cages. Evaluation was performed 24 h after ozone exposure. Alveolar fluid clearance (AFC) was evaluated using fluorescein isothiocyanate tagged albumin. Differential cell counts, total protein levels, cytokine concentrations, myeloperoxidase activity and markers of oxidative stress, i.e. malondialdehyde and peroxynitrite, were determined in bronchoalveolar lavage (BAL) and lung homogenates (LH). Levels of AMPK-Thr172 phosphorylation and basolateral membrane Na(+)-K(+)-ATPase abundance were determined by Western blot. Results: In control mice, ozone exposure induced lung inflammation as evidence by increased leukocyte count, protein concentration in BAL and myeloperoxidase activity, pro-inflammatory cytokine levels in LH. Increases in peroxynitrite levels (3 vs 4.4 nM, p = 0.02) and malondialdehyde concentrations (110 vs 230 μmole/g wet tissue) were detected in LH obtained from ozone-exposed control mice. Ozone exposure consistently increased phosphorylated AMPK-Thr172 to total AMPK ratio by 80% in control mice. Ozone exposure causes increases in AFC and basolateral membrane Na(+)-K(+)-ATPase abundance in control mice which did not occur in AMPKα1 deficient mice. Conclusions: Our results collectively suggest that AMPK activation participates in ozone-induced increases in AFC, inflammation and oxidative stress. Further studies are needed to understand how the AMPK pathway may provide a novel approach for the prevention of ozone-induced lung injury.